Cancer-associated fibroblasts in colorectal cancer S Kamali Zonouzi, PS Pezeshki, S Razi, N Rezaei Clinical and Translational Oncology, 1-13, 2022 | 40 | 2022 |
Immune checkpoint inhibition in COVID-19: risks and benefits PS Pezeshki, N Rezaei Expert Opinion on Biological Therapy 21 (9), 1173-1179, 2021 | 36 | 2021 |
Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 17 | 2023 |
Immune checkpoint inhibition in classical Hodgkin lymphoma PS Pezeshki, M Eskian, MR Hamblin, N Rezaei Expert Review of Anticancer Therapy 21 (9), 1003-1016, 2021 | 11 | 2021 |
Age and gender differences of basic electrocardiographic values and abnormalities in the general adult population; Tehran Cohort Study P Ahmadi, A Afzalian, A Jalali, S Sadeghian, F Masoudkabir, A Oraii, ... BMC Cardiovascular Disorders 23 (1), 303, 2023 | 9 | 2023 |
Advances in pharmacotherapy for neuroblastoma PS Pezeshki, A Moeinafshar, F Ghaemdoust, S Razi, M Keshavarz-Fathi, ... Expert Opinion on Pharmacotherapy 22 (17), 2383-2404, 2021 | 8 | 2021 |
Resistance mechanisms to programmed cell death protein 1 and programmed death ligand 1 inhibitors PS Pezeshki, P Mahdavi Sharif, N Rezaei Expert Opinion on Biological Therapy 21 (12), 1575-1590, 2021 | 6 | 2021 |
Investigation of the female infertility risk associated with anti-cancer therapy A Lavafian, PS Pezeshki, N Rezaei Clinical and Translational Oncology 25 (7), 1893-1905, 2023 | 4 | 2023 |
The role of interleukins in pathogenesis and prognosis of atrial fibrillation ME Lotfi, PS Pezeshki, N Rezaei Expert Review of Clinical Immunology 19 (6), 585-597, 2023 | 4 | 2023 |
Diagnostic role of circulating endocan levels in obstructive sleep apnea: a systematic review and Meta-analysis AH Behnoush, A Khalaji, N Amirkhani, PS Pezeshki Angiology 75 (6), 505-516, 2024 | 3 | 2024 |
The clinical application of ctDNA to predict response to neoadjuvant chemoradiotherapy in patients with locally-advanced rectal cancer PS Pezeshki, R Ghalehtaki Biomarker Research 11 (1), 81, 2023 | 3 | 2023 |
Incidence of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without antiviral medications: A retrospective study SM Mousavi Movahed, H Akhavizadegan, F Dolatkhani, S Akbarpour, ... Plos one 18 (10), e0292746, 2023 | 2 | 2023 |
Coronavirus disease 2019 (COVID-19) in pediatric patients with autoimmune disorders P Sadeghi, PS Pezeshki, N Rezaei European Journal of Pediatrics 182 (7), 2967-2988, 2023 | 2 | 2023 |
Feature tracking cardiac magnetic resonance imaging to assess cardiac manifestations of systemic diseases PS Pezeshki, SM Ghorashi, G Houshmand, M Ganjparvar, H Pouraliakbar, ... Heart Failure Reviews, 1-11, 2023 | 2 | 2023 |
Prediabetes and major adverse cardiac events after acute coronary syndrome: An overestimated concept AH Behnoush, S Maleki, A Arzhangzadeh, A Khalaji, PS Pezeshki, ... Clinical Cardiology 47 (4), e24262, 2024 | 1 | 2024 |
7-year outcomes in diabetic patients after coronary artery bypass graft in a developing country PS Pezeshki, F Masoudkabir, M Pashang, A Vasheghani-Farahani, ... BMC Cardiovascular Disorders 23 (1), 248, 2023 | 1 | 2023 |
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy A Aghakhani, PS Pezeshki, N Rezaei Expert Opinion on Investigational Drugs, 2024 | | 2024 |
Whole‐exome sequencing to identify undiagnosed primary immunodeficiency disorders in children with community‐acquired sepsis, admitted in the pediatric intensive care unit E Rayzan, M Mirbeyk, PS Pezeshki, M Mohammadpour, B Yaghmaie, ... Pediatric Allergy and Immunology 34 (12), e14066, 2023 | | 2023 |
Adducted Thumb Syndrome HT Golroudbari, PS Pezeshki, N Rezeai Genetic Syndromes: A Comprehensive Reference Guide, 1-4, 2023 | | 2023 |
Atelosteogenesis (AO) Types I–III J Møgelvang, PS Pezeshki Genetic Syndromes: A Comprehensive Reference Guide, 1-5, 2023 | | 2023 |